Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Roche's Gazyva secures FDA nod in 2nd autoimmune indication
Gazyva won FDA approval to reduce relapse risk in patients 2 and older with frequently relapsing or steroid-dependent childhood-onset INS.
Donavyn Coffey
Sep 28, 2026 2:29pm
BioNTech to close sites in Germany after failed sale
Sep 28, 2026 10:59am
Hiring for Resilience in Life Sciences Sales
Brought to you by
Mix Talent
Lilly to expand global GLP-1 access by 2040
Sep 28, 2026 9:59am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
AbbVie notches FDA nod for Ceverel asset Juvmo in Parkinson's
Sep 28, 2026 8:15am
